Created at 12:31 a.m. Dec, 01, 2024
Author: cardamomo
Related Note: 1547242128167 1
Rationale for change

This card has a few issues.

Firstly, the treatment regimen is largely the same whether or not the patient is pre/postmenopausal, although EOC typically presents in postmenopausal women (1,2).

Secondly, the chemotherapy regimen is low yield, but outdated (1).

Thirdly, much of the extra is somewhat irrelevant to the card. Fertility preservation is only used in management of select malignant ovarian neoplasms (2,3) and TAH and BSO is standard of care in both pre and postmenopausal women (except in the case of early-stage EOS, for which fertility preservation can be considered) because EOC typically presents at an advanced stage and TAH and BSO is part of staging and surgical treatment (2).

If these changes are unable to be made, I would recommend that this content be integrated to the deck elsewhere or that new cards be generated to cover this content gap in treatment of ovarian neoplasms.

Sources
1. https://next.amboss.com/us/article/aO0QIT?q=epithelial%20ovarian%20cancer%20treatment#Yf12090dc1faa443872104a241e3ecb99

2. https://www.uptodate.com/contents/overview-of-epithelial-carcinoma-of-the-ovary-fallopian-tube-and-peritoneum?search=epithelial%20ovarian%20cancer%20treatment&source=search_result&selectedTitle=4%7E150&usage_type=default&display_rank=4#H6099451


3. Fertility preservation option in young women with ovarian cancer
National Institutes of Health (NIH) (.gov)
https://pmc.ncbi.nlm.nih.gov › articles › PMC5549777

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Empty field
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#OME::05_Obstetrics_and_Gynecology::01_Gynecology::02_Gynecology_Oncology::04_Ovarian_Cancer #AK_Step2_v12::#SketchyOBGYN::07_Gyn_Neoplasia::01_Ovarian_Cysts_&_Neoplasia::03_Epithelial_Ovarian_Cancer #AK_Step2_v12::#Subjects::Obstetrics_&_Gynecology::01_Gynecology::Ovary::Ovarian_Cancer #AK_Step2_v12::#B&B::11_Obstetrics_and_Gynecology::02_Gynecology::12_Ovarian_Neoplasia #AK_Step2_v12::Original_decks::Dorian::obgyn::ome::gyn::ovarian_cancer #AK_Step2_v12::#Resources_by_rotation::ObGyn::ome::gyn::ovarian_cancer #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::2obgyn #AK_Step2_v12::!Shelf::ObGyn::no_dupes::only_step2 #AK_Step2_v12::#Subjects::Obstetrics_&_Gynecology::01_Gynecology::Ovary::Ovarian_Cancer::*Management #AK_Step2_v12::#OME::Clinical::05_Obstetrics_and_Gynecology::01_Gynecology::02_Gynecology_Oncology::04_Ovarian_Cancer #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3)